Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

Avaí Bio's joint venture Insulinova entered into a Research and Option Agreement with Ospedale San Raffaele (OSR) to collaborate on developing an encapsulated cell therapy for diabetes. The program combines OSR's stem cell-derived beta cell expertise with Austrianova's Cell-in-a-Box technology to evaluate immune protection and cell survival.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.